Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1363943 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
The development of a series of novel 1,2,3,4-tetrahydroisoquinolin-1-ones as antagonists of G protein-coupled receptor 40 (GPR40) is described. The synthesis, in vitro inhibitory values for GPR40, in vitro microsomal clearance and rat in vivo clearance data are discussed. Initial hits displayed high rat in vivo clearances that were higher than liver blood flow. Optimization of rat in vivo clearance was achieved and led to the identification of 15i, whose rat oral pharmacokinetic data is reported.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Paul S. Humphries, John W. Benbow, Paul D. Bonin, David Boyer, Shawn D. Doran, Richard K. Frisbie, David W. Piotrowski, Gayatri Balan, Bruce M. Bechle, Edward L. Conn, Kenneth J. Dirico, Robert M. Oliver, Walter C. Soeller, James A. Southers,